As “living” drugs, cell and gene therapies face more challenges in quality control and safety during drug development, production, clinical trials and commercialization. With a sound multi-omics platform, professional laboratory, data analysis and medical genetics scientists, Sequanta Technologies can provide services for discovery and preclinical bioanalytical studies, safety and CMC testing, and clinical trial sample testing.

We support cell therapies such as CAR-T, CAR-NK, iPSC and HSC, as well as gene therapies such as gene editing, AAV and mRNA. Our featured solutions include integrated vector insertion site and copy number analysis, gene editing on-target and off-target analysis, cell genome stability analysis, cell marker and differentiation characterization, cytokine and immune marker analysis, and vector sequencing We provide high quality services for drug submissions and clinical trials, and have worked with leading partners on several IIT/registered clinical trials, supported 2 BLA/NDA submissions and dozens of IND submissions, and complete thousands of clinical sample tests.